Tandem Diabetes Care Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Tandem Diabetes Care

Access the complete profile.

Tandem Diabetes Care Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes	339113 Surgical Appliance & Supplies Manufacturing
Address	12400 High Bluff Drive San Diego, CA 92130

Tandem Diabetes Care's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Tandem Diabetes Care's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Tandem Diabetes Care is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Tandem Diabetes Care is a publicly traded company on NGM using the ticker symbol TNDM. Detailed information on company financials and operating reports can be found here: NGM: TNDM

Tandem Diabetes Care Annual Revenue and Growth Rate

Tandem Diabetes Care	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Tandem Diabetes Care's revenues are gauged from an analysis of company filings.

Investor Activity

Tandem Diabetes Care has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
September 11, 2012	43	73%	$50 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Tandem Diabetes Care is developing and marketing. Tandem Diabetes Care's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
M Recorded and downloadable software and hardware for use in managing diabetes; recorded and downloadable software and hardware for linking medical instruments and devices; electronic controllers for infusion and injection devices	11/13/2023
VARISOFT Infusion sets	06/12/2023
AUTOSOFT Infusion sets	06/12/2023

See all trademarks and details in the Full Report.

Market Share of Tandem Diabetes Care's Largest Competitors

A competitive analysis shows these companies are in the same general field as Tandem Diabetes Care, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Tandem Diabetes Care. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DEXCOM	San Diego, CA	100
TANDEM DIABETES CARE	San Diego, CA	54
NUVASIVE	San Diego, CA	42
AGENA BIOSCIENCE	San Diego, CA	3
HERON THERAPEUTICS	San Diego, CA	2
INNOVIVE	San Diego, CA	1

Future Competition: Tandem Diabetes Care's Fastest Growing Competitors

These companies are in the same general field as Tandem Diabetes Care and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)